Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

DUSA Pharmaceuticals: Small-Cap Biotech With a Healthy Cash Flow
Seeking Alpha
Monday, March 14, 2011 - 11:12am
tags:
DUSA pharmaceuticals, dermatology, Levulan photodynamic therapy, PDT
Who Will Win the Hepatitis C Market?
Seeking Alpha
Monday, March 14, 2011 - 10:44am
tags:
hepatitis C, Gilead Sciences, Merck, Bristol-Myers Squibb, Novartis, Pfizer, Vertex Pharmaceuticals, Pharmasset
Animal Health International, Inc. to merge with Lextron, Inc.
CP Wire
Monday, March 14, 2011 - 10:42am
tags:
animal health, Lextron, Animal Health International, M&A
Amgen Investors: ‘We Want A Dividend Already’
Pharmalot
Monday, March 14, 2011 - 10:21am
tags:
Amgen, dividends, investors
Dendreon's Golden Age Is Still in Its Infancy
Seeking Alpha
Monday, March 14, 2011 - 10:20am
tags:
Dendreon
Pozen's Success Will Depend on Execution of Unique Marketing Strategies
Seeking Alpha
Monday, March 14, 2011 - 10:19am
tags:
Pozen
Lilly Makes An ‘Irrevocable’ Offer to Acquire Janssen Business
Bloomberg
Monday, March 14, 2011 - 10:18am
tags:
Eli Lilly, animal health, Janssen Pharmaceuticals, JNJ, M&A
Gilead’s High Bar for AIDS Drugs Means New Development Withers
Bloomberg
Monday, March 14, 2011 - 10:16am
tags:
Gilead Sciences, AIDS, HIV, Merck, Bristol-Myers Squibb
Cadence Pharmaceuticals: A Rising Star
Seeking Alpha
Sunday, March 13, 2011 - 11:55am
tags:
Cadence Pharmaceuticals, Ofirmev, Bristol-Myers Squibb, pain management
Elan Announces First European Commission Approval Of Injectable Treatment Using Elan's NanoCrystal(R) Technology
Medical News Today
Sunday, March 13, 2011 - 11:39am
tags:
Elan, Nanocrystal, schizophrenia, Xeplion
FDA's fast-track approval of Makena could backfire on KV
Stl Today, MO
Sunday, March 13, 2011 - 11:36am
tags:
KV Pharmaceutical, Makena, preterm labor
Lupin to launch 10 drugs in Japan next fiscal
Business Standard, India
Sunday, March 13, 2011 - 11:32am
tags:
Lupin
Aeterna Zentaris and Yakult Honsha Sign a Development, Commercialization and Licensing Agreement for the development, registration and marketing of perifosine
PR-USA.net
Sunday, March 13, 2011 - 11:30am
tags:
Aeterna Zentaris, Yakult, perifosine, oncology, colon cancer
Durbin takes aim at Obama’s detente with drug industry
The Hill
Saturday, March 12, 2011 - 3:00pm
tags:
healthcare reform, Medicare
Seeking The Magic Pill
BusinessWorld
Saturday, March 12, 2011 - 2:57pm
tags:
R&D
Spencer Pharmaceutical Inc. Signs Agreement With Univalor, L.P.
PR-USA.net
Saturday, March 12, 2011 - 1:56pm
tags:
Spencer Pharmaceutical, Univalor, drug delivery, diabetes
Teva: A Defensive Stock With a Positive Outlook
Seeking Alpha
Saturday, March 12, 2011 - 1:54pm
tags:
Teva Pharmaceuticals
SCOLR Pharma, Inc. Receives Deficiency Letter from FDA on Pseudoephedrine Application
PR NewsWire
Saturday, March 12, 2011 - 1:53pm
tags:
Sclor Pharma, pseudoephedrine
Valeant Pharmaceuticals Completes Acquisition of PharmaSwiss S.A.
Bradenton Herald, FL
Saturday, March 12, 2011 - 1:51pm
tags:
Valeant Pharmaceuticals, PharmaSwiss, M&A
Is KV Pharmaceutical A Flat-Out Evil Company?
Forbes
Saturday, March 12, 2011 - 1:50pm
tags:
KV Pharmaceutical, 17P, preterm labor

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.